基于Mimics三维重建技术的胸腔镜肺段切除术治疗早期非小细胞肺癌的临床研究  

Clinical Study of Thoracoscopic Lung Segmentectomy for Early Non-Small Cell Lung Cancer Based on Mimics Three-Dimensional Computed Tomography Bronchography and Angiography Technique

作　　者：代祖建 林铿强 张楠 叶建刚 潘闪 许添辉 许德新 DAI Zu-jian;LIN Keng-qiang;ZHANG Nan;YE Jian-gang;PAN Shan;XU Tian-hui;XU De-xina(Department of Thoracic Surgery,Fuzhou Pulmonary Hospital in Fujian Province,Fuzhou,Fujian,350007,China)

机构地区：[1]福建省福州肺科医院胸外科,福建福州350007

出　　处：《现代生物医学进展》2024年第20期3929-3931,共3页Progress in Modern Biomedicine

基　　金：福建省卫健委科技计划项目(2021QNA066)。

摘　　要：目的:观察基于Mimics三维重建技术(3D-CTBA)的胸腔镜肺段切除术治疗早期非小细胞肺癌(NSCLC)的临床疗效。方法:回顾性分析87例我院接受胸腔镜肺段切除术的NSCLC患者的临床资料。按是否使用3D-CTBA分为对照组(未使用3D-CTBA)和实验组(使用3D-CTBA),例数分别为42例和45例。对比两组围术期相关指标、并发症发生情况及术后预后情况。结果:实验组围术期相关指标均优于对照组(P<0.05)。实验组的并发症发生率低于对照组(P<0.05)。两组随访期间均未出现术后复发、转移或病死。结论:基于3D-CTBA进行胸腔镜肺段切除术,可减轻NSCLC患者术中损伤,缩短手术时间,降低并发症的发生率,加快恢复进程。Objective:To observe the clinical efficacy of thoracoscopic lung segmentectomy based on Mimics three-dimensional computed tomography bronchography and angiography(3D-CTBA)in the treatment of early non-small cell lung cancer(NSCLC).Methods:The clinical data of 87 NSCLC patients who underwent thoracoscopic lung segmentectomy were retrospectively analyzed.Patients were divided into control group(without 3D-CTBA)and experimental group(with 3D-CTBA)according to the use of3D-CTBA,with 42 cases and 45 cases respectively.Perioperative indicators,complications and postoperative outcomes were compared between two groups.Results:The perioperative related indicators of the experimental group were better than those of the control group(P<0.05).The complication rate in the experimental group was lower than that in the control group(P<0.05).There was no postoperative recurrence,metastasis,or mortality during the follow-up period in both groups.Conclusion:Thoracoscopic lumpectomy based on3D-CTBA can reduce intraoperative injury,shorten operation time,reduce the incidence of complications,and accelerate the recovery process.

关 键 词：胸腔镜肺段切除术 Mimics三维重建技术 早期非小细胞肺癌 

分 类 号：R734.2[医药卫生—肿瘤]